AI Article Synopsis

  • Alendronate is commonly used to treat bone disorders by reducing bone loss, but it has drawbacks like poor absorption and side effects, so a local delivery method is explored.
  • A scaffold made from bovine hydroxyapatite-gelatin and alendronate, cross-linked with varying levels of glutaraldehyde, was created and studied for its physical and biological properties.
  • Results showed that increasing glutaraldehyde concentration improved porosity but decreased compressive strength; however, the scaffold remained safe for cells, indicating potential for effective bone regeneration.

Article Abstract

Objectives: Alendronate are widely used in the treatment of bone disorders characterized by inhibit osteoclast-mediated bone resorption such as Paget's disease, fibrous dysplasia, myeloma, bone metastases and osteoporosis. In recent studies alendronate improves proliferation and differentiation of osteoblasts, thereby facilitating for bone regeneration. The disadvantages of this class are their poor bioavailability and side effects on oral and intravenous application such as stomach irritation and osteonecrosis in jaw. Thus, local treatment of alendronate is needed in order to achieve high concentration of drug. Bovine hydroxyapatite-gelatin scaffold with alendronate was studied. Glutaraldehyde was used as cross-linking agent, increase the characteristics of this scaffold. The objectives of this study were to manufacture and characterize alendronate scaffold using bovine hydroxyapatite-gelatin and crosslinked by glutaraldehyde.

Methods: Preparation of cross-linked bovine hydroxyapatite-gelatin and alendronate scaffold with different concentration of glutaraldehyde (0.00, 0.50, 0.75, and 1.00%). The scaffolds were characterized for compressive strength, porosity, density, swelling ratio, degradation, and cytotoxicity (the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide assay, shorted as MTT assay).

Results: Bovine hydroxyapatite-gelatin-alendronate scaffold cross-linked with glutaraldehyde showed lower density than without glutaraldehyde. As glutaraldehyde concentration increased, porosity also increased. Eventually, it reduced compressive strength. Swelling ratio and degradation was negatively dependent on glutaraldehyde concentration. In addition, the scaffold has a good safety by MTT assay.

Conclusions: Bovine hydroxyapatite-gelatin-alendronate scaffold was fabricated with various concentrations of glutaraldehyde. The presence of glutaraldehyde on bovine hydroxyapatite-gelatin-alendronate is safe and suitable candidate scaffold for bone regeneration.

Download full-text PDF

Source
http://dx.doi.org/10.1515/jbcpp-2020-0422DOI Listing

Publication Analysis

Top Keywords

bovine hydroxyapatite-gelatin-alendronate
16
hydroxyapatite-gelatin-alendronate scaffold
12
bone regeneration
12
bovine hydroxyapatite-gelatin
12
scaffold
9
glutaraldehyde
9
scaffold cross-linked
8
cross-linked glutaraldehyde
8
alendronate scaffold
8
compressive strength
8

Similar Publications

Article Synopsis
  • Alendronate is commonly used to treat bone disorders by reducing bone loss, but it has drawbacks like poor absorption and side effects, so a local delivery method is explored.
  • A scaffold made from bovine hydroxyapatite-gelatin and alendronate, cross-linked with varying levels of glutaraldehyde, was created and studied for its physical and biological properties.
  • Results showed that increasing glutaraldehyde concentration improved porosity but decreased compressive strength; however, the scaffold remained safe for cells, indicating potential for effective bone regeneration.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!